Artificial Organs - Worldwide Market Challenges & Opportunities

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.INDUSTRY OVERVIEW
Artificial Organs Revolutionize Medical Technology Industry
Current and Future Analysis
Market Outlook
Opportunities Abound for Bioartificial Organs
Bionics to Play Crucial Role
Economic Situation Plays a Pivotal Role in ESRD Treatment Accessibility
Growth Drivers
Growth Inhibitors
3.MARKET TRENDS AND ISSUES
Higher Development Costs and Lengthy Regulatory Process – Stumbling Blocks- for Product Commercialization
Lack of Requisite Expertise – Hindering Implantation Process
Alliances to Play a Key Role
Aging Population – A Boosting Factor
Anemia - A Growing Concern among Renal Failure Patients
Swelling ESRD Patient Population Spurs Dialyzers Growth
Growing Need for Efficient Control and Easy Usage
Expiry of Warranty Provides New Opportunities
Xenotransplantation - Other Alternative to Donor Organ Shortage
Artificial Organs from Cloned Animal Cells – A Promising Trend
Immunosuppressants Hold Promise in Artificial Organs Market
Move Towards Smaller Implantable Devices
Barriers to Entry Significantly High in Dialyzers Market
Reuse of Dialyzers – A Major Issue in Dialysis Industry
Poor Reimbursement Environment Stymies Innovation
Pricing Trends in Artificial Organs
4.COMPETITIVE SCENARIO
Competition Heating Up in Artificial Pancreas Domain
Fresenius Medical Care – Leads the Worldwide Dialysis Equipment and Supplies- Market
Competitive Landscape of Artificial Kidney or Dialyzers Market
Synthetic Dialyzers to Attain Mainstay
Asahi Kasei Medical Dominates Japanese Dialyzers Market
Competitive Landscape of Ventricular Assist Devices
Liver Assist Devices Competitive Landscape
5.PRODUCT FACTS
Artificial Organs
Artificial Heart
Artificial Kidneys
Artificial Liver
Artificial Pancreas
Artificial Lungs
Organ Rejection – A Major Barrier to Transplantation
Other Issues for Organ Transplantation
Combined Organ Transplantation – Gaining Attention
6.REGULATORY ENVIRONMENT
Regulatory Environment in the US
Regulatory Environment in Europe
7.CORPORATE DEVELOPMENTS
Thoratec Receives FDA Approval for HeartMate II®
Asahi Kasei Institutes a Sales Subsidiary in Taiwan
Arbios Seeks CE Marking for SEPET™
Gambro Teams up with Debiotech for Developing Peritoneal Dialysis Cycler
Arbios Obtains US FDA Approval for Initiating Clinical Trial for SEPET™
Abiomed Obtains HDE Supplement Approval from FDA for AbioCor®- Implantable Artificial Heart
Ventracor Obtains CE Marking for VentrAssist™ LVAD
Fresenius Medical Care Takes Over Renal Solutions, Inc.
Arbios Inks Exclusive Agreement with NxStage for SEPET™
WorldHeart Completes First Multi-Day Animal Study of PediaFlow™ VAD
Xcorporeal Completes Merger with CT Holdings
Nikkiso Collaborates with Nipro for Overseas Launch of Dialysis Systems
Ege University to Initiate Artificial Heart Project
Vascutek Buys Kohler Chemie’s Heart Valve Business
NovaThera Partners with NovaLung to Develop Advanced Artificial Lung
Aksys Quits Kidney Dialysis Machines Business
Twardowski Terminates License Agreement with Aksys
Asahi Kasei Medical Fortifies Competence in Artificial Kidney Production
Fresenius Medical Care Enhances Dialyzer Output
HepaLife Appoints Stem Cell Systems for Bioreactor Development
Gambro Unveils AK 96™ Dialyzer
Nipro Introduces Artificial Kidney Dialyzer in Overseas Markets
University of Michigan Develops Artificial Lungs
USC Researchers Develop Argus II Retinal Prosthesis System for Retinal Implant
Researchers Develop Cell Manipulation Technique for Organ Regeneration- Process
Terumo to Introduce First CE Mark LVAS in Europe
Advanced Technique for Nerve Re-Growth Developed
8.MAJOR PLAYERS
Abbott Diabetes Care (USA)
Abiomed, Inc. (USA)
Arbios Systems, Inc. (USA)
Asahi Kasei Kuraray Medical Co., Ltd (Japan)
Baxter International, Inc. (USA)
F.Hoffmann-La Roche Ltd. (Switzerland)
Fresenius Medical Care AG & Co. KgaA (Germany)
Fresenius Medical Care North America Inc (USA)
Fresenius Kawasumi (Japan)
Gambro AB (Sweden)
Hepalife Technologies, Inc. (USA)
Jarvik Heart, Inc. (USA)
MC3, Inc. (USA)
Medtronic, Inc. (USA)
MicroMed Cardiovascular, Inc. (USA)
Nikkiso Co., Ltd. (Japan)
Nipro Corporation (Japan)
SynCardia Systems, Inc. (USA)
Terumo Corporation (Japan)
Thoratec Corporation (USA)
Toray Medical Co., Ltd. (Japan)
Ventracor Limited (Australia)
Vital Therapies, Inc. (USA)
WorldHeart Corporation (USA)
9.GLOBAL MARKET ANALYTICS
Table 1: Percentage Breakdown of Leading Players in the Worldwide Dialysis Equipment and Supplies Market by Sales-
Table 2: Percentage Breakdown of Leading Players in the Worldwide Hemodialysis Equipment and Supplies Market by Sales –
Table 3: Percentage Breakdown of Leading Players in the Worldwide Peritoneal Dialysis Equipment and Supplies Market by Sales –
Table 4: Percentage Breakdown of Leading Players in the Worldwide Dialyzers Market by Unit Output –
Table 5: Percentage Breakdown of Leading Players in the Japanese Kidney Dialyzers Market by Sales –
Table 6: Percentage Breakdown of Leading Players in the Worldwide VADs Market by Sales –
Table 7: Global Artificial Organs Market by Product Segment for the Period 2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Artificial Organs Market by Product Segment for the Years 2008 & 2009
Table 9: Global Artificial Kidneys/Dialyzers Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Artificial Kidneys/Dialyzers Market by Region for the Years 2008 & 2009
Table 11: Global Insulin Pumps (External) Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Insulin Pumps (External) Market by Region for the Years 2008 & 2009
Companies Profiled